PMID: 9177063Apr 1, 1997Paper

Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994

Addiction
M FrischerL Berney

Abstract

There has been much speculation about the nature and extent of mortality among drug injectors in Glasgow. In order to determine injectors' mortality rate and compare this rate to the general population, identifier information from 459 drug injectors who received treatment for drug misuse in Glasgow between 1982 and 1994 was linked to the Scottish Mortality Register. The average duration of follow-up from cohort entry was 5.5 years and 10.2 years from commencement of drug injection. By the end of 1994, 53 cohort members had died. The average annual mortality rate of 1.8% was the same as that observed in a London cohort followed-up from 1969 to 1991. However, the excess mortality ratio (EMR) of 22.0 was almost double the London rate (11.9) because of the much lower average age of mortality (26.3 vs. 38.2 years). There was no significant time trend in EMR. Kaplan-Meier hazard analyzes show that younger patients and those who were HIV positive had significantly elevated mortality rates. The main cause of death was overdose, although it is unclear how many were accidental and how many intentional. Three of the six fatalities among HIV positive injectors were AIDS related. This study enables the first realistic assessment of the hypo...Continue Reading

References

Jun 1, 1992·British Journal of Addiction·S GreenN McKeganey
Oct 1, 1991·American Journal of Public Health·C A PerucciF Forastiere
Jan 1, 1991·The International Journal of the Addictions·A EngströmU Rydberg
Feb 9, 1985·British Medical Journal·A H GhodseG Edwards
Dec 1, 1985·Journal of Epidemiology and Community Health·D Hume, J Womersley
Feb 1, 1994·Journal of Epidemiology and Community Health·M DavoliC A Perucci
Feb 1, 1993·Journal of Epidemiology and Community Health·M FrischerN McKeganey
Mar 1, 1996·Addiction·M FarrellJ Strang

❮ Previous
Next ❯

Citations

Jan 1, 2004·Irish Journal of Medical Science·W CullenF D O'Kelly
Jan 20, 2011·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Lindsay M JenkinsPhillip O Coffin
Jul 9, 2005·Drug and Alcohol Dependence·Jürgen RehmAmbros Uchtenhagen
Jun 18, 2005·Drug and Alcohol Dependence·Kristen C OchoaAndrew R Moss
Jul 5, 2001·Addictive Behaviors·K C OchoaA R Moss
Oct 24, 2001·Drug and Alcohol Dependence·D RisserG Bauer
Jun 14, 2002·Drug and Alcohol Dependence·A PretiM De Coppi
May 7, 2003·Drug and Alcohol Dependence·Sandro GaleaKenneth Tardiff
Apr 27, 1999·Drug and Alcohol Dependence·S DarkeB Lind
Feb 11, 2000·Drug and Alcohol Dependence·J Neale
Nov 2, 2002·Addiction·Shane Darke, Joanne Ross
May 12, 2000·Journal of Evaluation in Clinical Practice·F Noble, P J Robson
Jun 7, 2003·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Sandro GaleaDavid Vlahov
Jun 7, 2003·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Boris SergeevMikhail Tikhonov
Jun 7, 2003·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Matthew HickmanGerry Stimson
Apr 3, 2001·BMJ : British Medical Journal·M B GabbayD A Zador
Apr 17, 2001·Gut·A H Mohsen, UNKNOWN Trent HCV Study Group
Jan 22, 2011·BMC Infectious Diseases·Arfon G M T PowellDavid J Galloway
Mar 14, 2007·BMC Public Health·Kyle T BernsteinSandro Galea
Aug 24, 2013·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Cathrine LundKnut E Hovda
Sep 8, 2006·Journal of Addictive Diseases·Anita Srivastava, Meldon Kahan
Aug 7, 2008·Journal of Addictive Diseases·Alexander MontoTeresa L Wright
Nov 27, 2014·European Journal of Gastroenterology & Hepatology·Robert FlisiakErin E Gower
Nov 20, 2014·AIDS·Bradley M Mathers, Louisa Degenhardt
Apr 5, 2013·Bulletin of the World Health Organization·Bradley M MathersMathew Hickman
Jun 3, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·R MugaA Muñoz
Feb 14, 2009·The Journal of Nutrition, Health & Aging·I CromeP Crome
Aug 24, 2010·Drug and Alcohol Dependence·Amy S B BohnertSandro Galea
Feb 17, 2009·Forensic Science International : Synergy·Mu'men S HadidiKamal A Hadidi
Feb 1, 2005·Addiction·Joanne Neale, Michele Robertson
Aug 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sharon J HutchinsonDavid J Goldberg
Jan 15, 2008·Addiction·Amy GibsonSusannah O'Brien
Sep 13, 2006·Forensic Science International : Synergy·Anna K JönssonJohan Ahlner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.